Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Preparation and use of new beta3-adrenoceptor agonists covered in recent patent

Oct. 11, 2001

TheraMed now called MaxCyte

Oct. 11, 2001

Tularik designs LXR receptor modulators and discusses possible uses thereof

Oct. 9, 2001

New study finds chromium picolinate plus biotin controls blood sugar levels in type 2 diabetics

Oct. 9, 2001

Aniline thyroid hormone receptor agonists presented by BMS team

Oct. 8, 2001

Agonists at PPAR receptors described by Merck for Rx of diabetes, etc.

Oct. 8, 2001

Nastech initiates phase I clinical trial of intranasal somatropin

Oct. 8, 2001

Lead IGFBP-3 ligand inhibitor identified at Neurocrine Biosciences

Oct. 5, 2001

Nonhormonal strategies for menopausal symptoms a hot topic

Oct. 5, 2001

First monthly vaginal contraceptive ring granted marketing approval in the U.S.

Oct. 5, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
Insilico Medicine synthesizes new Nav1.8 blockers
BioWorld Science
Insilico Medicine Inc. has identified sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers that are potentially useful for the treatment of pain.